Prostate Cancers Detected During 5α-Reductase Inhibitor Use Are Smaller, De-Differentiated, But Confined when Compared To Controls

Rationale: To compare cancers detected during use of 5α-reductase inhibitors (5αRI) with cancers detected in untreated controls stratified for tumor size. Methods: Prostate biopsies were performed on 235 consecutive patients “for cause” (elevated or rising PSA, positive digital rectal examination, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Fred, Badalament, Robert A., Hu, Chen, Bousho, Ingrid, Tsodikov, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297839/
https://www.ncbi.nlm.nih.gov/pubmed/22408685
http://dx.doi.org/10.7150/jca.4123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297839/
https://www.ncbi.nlm.nih.gov/pubmed/22408685
http://dx.doi.org/10.7150/jca.4123

Ejemplares similares